| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 MUC1 ZNF607 ZNF559 ZNF546 ZNF124 | 3.26e-05 | 1459 | 30 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 8.05e-04 | 28 | 30 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 8.20e-04 | 123 | 30 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 8.79e-04 | 1412 | 30 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.05e-03 | 32 | 30 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.05e-03 | 32 | 30 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.11e-03 | 171 | 30 | 3 | GO:0015103 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide catabolic process | 1.15e-04 | 63 | 31 | 3 | GO:0030811 | |
| GeneOntologyBiologicalProcess | regulation of glycolytic process | 1.15e-04 | 63 | 31 | 3 | GO:0006110 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide catabolic process | 1.15e-04 | 63 | 31 | 3 | GO:0033121 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate catabolic process | 2.51e-04 | 82 | 31 | 3 | GO:0043470 | |
| GeneOntologyBiologicalProcess | regulation of ATP metabolic process | 3.41e-04 | 91 | 31 | 3 | GO:1903578 | |
| GeneOntologyBiologicalProcess | glycolytic process | 5.95e-04 | 110 | 31 | 3 | GO:0006096 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide metabolic process | 6.27e-04 | 112 | 31 | 3 | GO:1900542 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide metabolic process | 6.44e-04 | 113 | 31 | 3 | GO:0006140 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 6.60e-04 | 114 | 31 | 3 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 7.12e-04 | 117 | 31 | 3 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 7.12e-04 | 117 | 31 | 3 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 7.48e-04 | 119 | 31 | 3 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 7.66e-04 | 120 | 31 | 3 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 7.85e-04 | 121 | 31 | 3 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 8.23e-04 | 123 | 31 | 3 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 8.43e-04 | 124 | 31 | 3 | GO:0009134 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide catabolic process | 8.65e-04 | 29 | 31 | 2 | GO:0030813 | |
| GeneOntologyBiologicalProcess | positive regulation of glycolytic process | 8.65e-04 | 29 | 31 | 2 | GO:0045821 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide catabolic process | 8.65e-04 | 29 | 31 | 2 | GO:0033123 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 1.01e-03 | 132 | 31 | 3 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 1.01e-03 | 132 | 31 | 3 | GO:0009179 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 1.25e-03 | 142 | 31 | 3 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 1.27e-03 | 143 | 31 | 3 | GO:0009185 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 1.43e-03 | 149 | 31 | 3 | GO:0009132 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.49e-03 | 38 | 31 | 2 | GO:0015701 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.54e-03 | 153 | 31 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.81e-03 | 42 | 31 | 2 | GO:0099560 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.82e-03 | 162 | 31 | 3 | GO:0015748 | |
| GeneOntologyBiologicalProcess | regulation of generation of precursor metabolites and energy | 2.05e-03 | 169 | 31 | 3 | GO:0043467 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 2.05e-03 | 169 | 31 | 3 | GO:0009154 | |
| HumanPheno | Hyperchloremic acidosis | 1.67e-04 | 13 | 8 | 2 | HP:0001995 | |
| HumanPheno | Hypokalemia | 1.90e-04 | 79 | 8 | 3 | HP:0002900 | |
| HumanPheno | Abnormal erythrocyte physiology | 2.24e-04 | 15 | 8 | 2 | HP:0020054 | |
| MousePheno | acidemia | 2.91e-05 | 7 | 17 | 2 | MP:0003030 | |
| MousePheno | decreased circulating bicarbonate level | 6.23e-05 | 10 | 17 | 2 | MP:0003017 | |
| MousePheno | metabolic acidosis | 9.12e-05 | 12 | 17 | 2 | MP:0012551 | |
| MousePheno | abnormal blood pH regulation | 1.08e-04 | 13 | 17 | 2 | MP:0003027 | |
| MousePheno | abnormal circulating bicarbonate level | 1.45e-04 | 15 | 17 | 2 | MP:0003015 | |
| MousePheno | abnormal bicarbonate level | 1.87e-04 | 17 | 17 | 2 | MP:0031394 | |
| MousePheno | abnormal bicarbonate homeostasis | 2.11e-04 | 18 | 17 | 2 | MP:0031393 | |
| MousePheno | increased urine calcium level | 3.17e-04 | 22 | 17 | 2 | MP:0005441 | |
| MousePheno | abnormal urine pH | 4.11e-04 | 25 | 17 | 2 | MP:0009348 | |
| MousePheno | acidosis | 5.16e-04 | 28 | 17 | 2 | MP:0003031 | |
| MousePheno | abnormal urine calcium level | 6.76e-04 | 32 | 17 | 2 | MP:0002985 | |
| Domain | KRAB | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 4.39e-09 | 358 | 31 | 9 | PS50805 |
| Domain | KRAB | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 4.39e-09 | 358 | 31 | 9 | PF01352 |
| Domain | KRAB | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 5.72e-09 | 369 | 31 | 9 | SM00349 |
| Domain | KRAB | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 5.85e-09 | 370 | 31 | 9 | IPR001909 |
| Domain | - | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 1.03e-06 | 679 | 31 | 9 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 1.23e-06 | 693 | 31 | 9 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 1.24e-06 | 694 | 31 | 9 | IPR013087 |
| Domain | K_chnl_inward-rec_Kir2.2 | 2.67e-06 | 2 | 31 | 2 | IPR003272 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 3.08e-06 | 775 | 31 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 3.15e-06 | 777 | 31 | 9 | PS00028 |
| Domain | Znf_C2H2-like | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 3.84e-06 | 796 | 31 | 9 | IPR015880 |
| Domain | Znf_C2H2 | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 4.21e-06 | 805 | 31 | 9 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 4.34e-06 | 808 | 31 | 9 | SM00355 |
| Domain | K_chnl_inward-rec_Kir_N | 7.99e-06 | 3 | 31 | 2 | IPR013673 | |
| Domain | IRK_N | 7.99e-06 | 3 | 31 | 2 | PF08466 | |
| Domain | zf-C2H2_6 | 1.11e-05 | 314 | 31 | 6 | PF13912 | |
| Domain | Band3_cytoplasmic_dom | 9.53e-05 | 9 | 31 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 9.53e-05 | 9 | 31 | 2 | PF07565 | |
| Domain | - | 9.53e-05 | 9 | 31 | 2 | 3.40.1100.10 | |
| Domain | PTrfase/Anion_transptr | 1.19e-04 | 10 | 31 | 2 | IPR016152 | |
| Domain | HCO3_cotransp | 1.19e-04 | 10 | 31 | 2 | PF00955 | |
| Domain | HCO3_transpt_euk | 1.19e-04 | 10 | 31 | 2 | IPR003020 | |
| Domain | HCO3_transpt_C | 1.19e-04 | 10 | 31 | 2 | IPR011531 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 3.15e-04 | 16 | 31 | 2 | IPR013518 | |
| Domain | IRK | 3.15e-04 | 16 | 31 | 2 | PF01007 | |
| Domain | - | 3.15e-04 | 16 | 31 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 3.15e-04 | 16 | 31 | 2 | IPR016449 | |
| Domain | Ig_E-set | 1.29e-02 | 104 | 31 | 2 | IPR014756 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.46e-04 | 10 | 26 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.46e-04 | 10 | 26 | 2 | MM15073 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 5.49e-04 | 19 | 26 | 2 | MM15194 | |
| Pubmed | 5.50e-07 | 181 | 31 | 5 | 37372979 | ||
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 7.69e-07 | 2 | 31 | 2 | 15705530 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24121512 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 8083233 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 11410627 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17640933 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 10904001 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 8921409 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 20798526 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 32990585 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 16177047 | ||
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 9529344 | ||
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 7580148 | ||
| Pubmed | Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. | 2.15e-05 | 8 | 31 | 2 | 27930290 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 14960569 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 10049592 | ||
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 16472605 | ||
| Pubmed | PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. | 1.17e-04 | 18 | 31 | 2 | 21511879 | |
| Pubmed | 2.66e-04 | 27 | 31 | 2 | 17273973 | ||
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 3.52e-04 | 31 | 31 | 2 | 17473172 | |
| Pubmed | 4.44e-04 | 405 | 31 | 4 | 38187761 | ||
| Pubmed | 4.75e-04 | 36 | 31 | 2 | 37497580 | ||
| Cytoband | 19p13.2 | 4.97e-04 | 229 | 31 | 3 | 19p13.2 | |
| Cytoband | 19q13.12 | 1.10e-03 | 72 | 31 | 2 | 19q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.95e-03 | 797 | 31 | 4 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 5.06e-03 | 157 | 31 | 2 | chr4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 8.14e-03 | 1192 | 31 | 4 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 8.32e-03 | 203 | 31 | 2 | chr17p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF567 ZNF571 ZNF878 ZNF33B ZNF439 ZNF607 ZNF559 ZNF546 ZNF124 | 1.16e-07 | 718 | 23 | 9 | 28 |
| GeneFamily | Potassium voltage-gated channel subfamily J | 1.84e-04 | 16 | 23 | 2 | 276 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.76e-02 | 161 | 23 | 2 | 593 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.32e-06 | 181 | 31 | 4 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-06 | 182 | 31 | 4 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-06 | 183 | 31 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 184 | 31 | 4 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.98e-06 | 185 | 31 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.68e-04 | 155 | 31 | 3 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 157 | 31 | 3 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Club-club-13|World / Class top | 1.91e-04 | 162 | 31 | 3 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | Club-club-12|World / Class top | 2.02e-04 | 165 | 31 | 3 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 167 | 31 | 3 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 2.17e-04 | 169 | 31 | 3 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.24e-04 | 171 | 31 | 3 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 171 | 31 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 174 | 31 | 3 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.44e-04 | 176 | 31 | 3 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 179 | 31 | 3 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 180 | 31 | 3 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.61e-04 | 180 | 31 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 181 | 31 | 3 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 181 | 31 | 3 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 181 | 31 | 3 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 181 | 31 | 3 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 184 | 31 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-04 | 185 | 31 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 31 | 3 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 186 | 31 | 3 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 2.92e-04 | 187 | 31 | 3 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-04 | 187 | 31 | 3 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 188 | 31 | 3 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 189 | 31 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | bb3b396d78887d5d6f93a05c8ed4d703591bf33f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-04 | 191 | 31 | 3 | e96184aee03175fd9f1da11fa2b89d95ba58b817 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.15e-04 | 192 | 31 | 3 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 192 | 31 | 3 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 192 | 31 | 3 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | 4842a55650fc4687c9184d498a8c05c259d15186 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.20e-04 | 193 | 31 | 3 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.25e-04 | 194 | 31 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.34e-04 | 196 | 31 | 3 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 3.34e-04 | 196 | 31 | 3 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 197 | 31 | 3 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | 82e83b4e4f54f9aa3a4a7bbf48b6dd603adeb69b | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | 8f894a4f0d34289f19d227788466b9fb4be15d54 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-04 | 197 | 31 | 3 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.45e-04 | 198 | 31 | 3 | bfad1c51cf884ff7ce89f8278820800582541dc7 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.45e-04 | 198 | 31 | 3 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-04 | 198 | 31 | 3 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-04 | 198 | 31 | 3 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.45e-04 | 198 | 31 | 3 | 6372e65242236c497d9b3be147092897c1609d22 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 7c66953ff6d8f16f4decd23c85232990d2d8c6c4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 3a954d9d542e52c9b181f0850a09b1bff0a0c82d | |
| Disease | Renal Tubular Acidosis, Type II | 9.99e-07 | 2 | 30 | 2 | C0268435 | |
| Disease | Renal tubular acidosis | 5.99e-06 | 4 | 30 | 2 | C0001126 | |
| Disease | renal tubular acidosis (is_implicated_in) | 5.99e-06 | 4 | 30 | 2 | DOID:14219 (is_implicated_in) | |
| Disease | Distal Renal Tubular Acidosis | 9.97e-06 | 5 | 30 | 2 | C1704380 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 2.79e-05 | 8 | 30 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 1.04e-04 | 15 | 30 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | fasting blood glucose change measurement | 4.86e-04 | 32 | 30 | 2 | EFO_0010120 | |
| Disease | health study participation | 1.01e-03 | 195 | 30 | 3 | EFO_0010130 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.94e-03 | 64 | 30 | 2 | DOID:4947 (is_marker_for) | |
| Disease | behavioural disinhibition measurement | 2.65e-03 | 75 | 30 | 2 | EFO_0006946 | |
| Disease | bipolar disorder | 2.65e-03 | 577 | 30 | 4 | MONDO_0004985 | |
| Disease | Esophageal Neoplasms | 2.86e-03 | 78 | 30 | 2 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 2.86e-03 | 78 | 30 | 2 | C0546837 | |
| Disease | calcium measurement | 3.59e-03 | 628 | 30 | 4 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YHTTSHPGTHKVYVE | 46 | P02730 | |
| EFKDHHYYLSGVHGS | 406 | O60423 | |
| DYSHFHKTYEVPSTP | 341 | Q14500 | |
| DTYHPMSEYPTYHTH | 1201 | P15941 | |
| AGKHHYSYLSDFETP | 16 | Q86VQ0 | |
| EHEHLNHYNSYKSPF | 591 | Q9HCJ2 | |
| HYAHTDCPGHADYVK | 121 | P49411 | |
| VYFKRNYPHIGHTDH | 1291 | O15439 | |
| SRVFHSYSPYDHKIG | 421 | Q5VV42 | |
| HKHPVTTVHDRLYGY | 331 | Q8TAL5 | |
| GYYSVNTFKEHHSTP | 636 | Q8IZU9 | |
| KHHSHREFPFYGDYG | 36 | P15515 | |
| KGGTYPRRYHVSVHH | 271 | Q99759 | |
| PRRYHVSVHHKDYSD | 276 | Q99759 | |
| DYSHFHKTYEVPSTP | 341 | B7U540 | |
| DPAGTIDKFHYGTHY | 2146 | Q6ZNJ1 | |
| HYEKSFHKHSATPNY | 146 | Q96B86 | |
| YHHIEPFCKLTGYSH | 101 | Q7RTV5 | |
| YLIDHHRTHTGEKPY | 491 | Q8N184 | |
| HYRTHTGEKPYECHE | 571 | Q06732 | |
| GRDHEYTDHPSKGSY | 286 | Q8N7X1 | |
| QLTVHHRFHYGEKPY | 211 | Q96SK3 | |
| HLTQHYRIHTGEKPY | 511 | Q86UE3 | |
| FRHSHSPAHKYYLAT | 1271 | Q6N022 | |
| SHLYSDHYSPSGRHR | 16 | Q86WS5 | |
| LHYHERTHTGEKPYV | 221 | Q15973 | |
| HHTIYIGVHVPKSYR | 26 | Q9Y6R1 | |
| RPYTHKEYVETFSHS | 211 | Q9BR84 | |
| HLTYHQRVHTGEKPY | 321 | Q7Z3V5 | |
| YHFFLYKHTHEGDPL | 236 | Q6IBS0 | |
| SFHYHERTHTGEKPY | 381 | C9JN71 | |
| SFRYHERTHTGEKPY | 396 | Q8NDP4 |